Merck to acquire San Diego biotech company for $10.8B

Merck announced April 16 that it entered into a definitive agreement to acquire Prometheus Biosciences Inc. for approximately $10.8 billion. 

Related Keywords

California ,United States ,Robert Davis ,Mark Mckenna ,Imago Biosciences Inc ,Exchange Commission ,Latham Watkins ,Centerview Partners ,Goldman Sachs Co ,Prometheus Biosciences Inc ,Wharton Garrison ,Morgan Stanley Co ,San Diego Based ,Prometheus Biosciences ,Rahway Based Merck ,Hart Scott Rodino Antitrust Improvements ,Goldman Sachs ,Imago Biosciences ,